Thrivent Financial for Lutherans’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-42,951
| Closed | -$316K | – | 2452 |
|
|
2023
Q2 | $316K | Sell |
42,951
-1,050
| -2% | -$9.74K | ﹤0.01% | 2317 |
|
|
2023
Q1 | $456K | Sell |
44,001
-1,543
| -3% | -$18.7K | ﹤0.01% | 2166 |
|
|
2022
Q4 | $538K | Sell |
45,544
-329
| -0.7% | -$5.09K | ﹤0.01% | 2082 |
|
|
2022
Q3 | $963K | Buy |
45,873
+1,941
| +4% | +$54K | ﹤0.01% | 1705 |
|
|
2022
Q2 | $1.36M | Buy |
43,932
+4,953
| +13% | +$169K | ﹤0.01% | 1489 |
|
|
2022
Q1 | $1.6M | Sell |
38,979
-43,458
| -53% | -$1.92M | ﹤0.01% | 1486 |
|
|
2021
Q4 | $3.58M | Buy |
82,437
+69,944
| +560% | +$3.16M | 0.01% | 1041 |
|
|
2021
Q3 | $626K | Buy |
12,493
+402
| +3% | +$24.3K | ﹤0.01% | 2077 |
|
|
2021
Q2 | $762K | Buy |
12,091
+47
| +0.4% | +$3.02K | ﹤0.01% | 1996 |
|
|
2021
Q1 | $1.12M | Buy |
12,044
+250
| +2% | +$25.6K | ﹤0.01% | 1796 |
|
|
2020
Q4 | $1.06M | Sell |
11,794
-322
| -3% | -$29.6K | ﹤0.01% | 1716 |
|
|
2020
Q3 | $1.25M | Sell |
12,116
-25,185
| -68% | -$2.71M | ﹤0.01% | 1439 |
|
|
2020
Q2 | $2.95M | Buy |
37,301
+525
| +1% | +$39.1K | 0.01% | 882 |
|
|
2020
Q1 | $2.13M | Buy |
36,776
+1,836
| +5% | +$106K | 0.01% | 925 |
|
|
2019
Q4 | $1.89M | Buy |
34,940
+91
| +0.3% | +$4.94K | 0.01% | 1080 |
|
|
2019
Q3 | $1.82M | Sell |
34,849
-498
| -1% | -$23.2K | 0.01% | 1052 |
|
|
2019
Q2 | $1.71M | Buy |
35,347
+1,124
| +3% | +$53.9K | 0.01% | 1091 |
|
|
2019
Q1 | $1.73M | Buy |
34,223
+2,627
| +8% | +$155K | 0.01% | 1045 |
|
|
2018
Q4 | $1.87M | Buy |
31,596
+1,596
| +5% | +$103K | 0.01% | 863 |
|
|
2018
Q3 | $1.98M | Buy |
30,000
+5,733
| +24% | +$335K | 0.01% | 912 |
|
|
2018
Q2 | $1.23M | Buy |
24,267
+669
| +3% | +$34.9K | ﹤0.01% | 1137 |
|
|
2018
Q1 | $1.24M | Buy |
23,598
+1,808
| +8% | +$90.1K | ﹤0.01% | 1105 |
|
|
2017
Q4 | $1.01M | Buy |
21,790
+430
| +2% | +$18.1K | ﹤0.01% | 1248 |
|
|
2017
Q3 | $864K | Buy |
21,360
+390
| +2% | +$14.1K | ﹤0.01% | 1255 |
|
|
2017
Q2 | $711K | Buy |
20,970
+1,410
| +7% | +$43.5K | ﹤0.01% | 1304 |
|
|
2017
Q1 | $568K | Sell |
19,560
-20,380
| -51% | -$620K | ﹤0.01% | 1458 |
|
|
2016
Q4 | $1.31M | Buy |
39,940
+870
| +2% | +$26.1K | 0.01% | 1018 |
|
|
2016
Q3 | $1.23M | Buy |
39,070
+23,850
| +157% | +$693K | 0.01% | 1048 |
|
|
2016
Q2 | $428K | Buy |
15,220
+1,140
| +8% | +$44.7K | ﹤0.01% | 1490 |
|
|
2016
Q1 | $512K | Buy |
14,080
+1,130
| +9% | +$39.9K | ﹤0.01% | 1356 |
|
|
2015
Q4 | $518K | Buy |
12,950
+400
| +3% | +$13.9K | ﹤0.01% | 1338 |
|
|
2015
Q3 | $358K | Buy |
12,550
+950
| +8% | +$31.3K | ﹤0.01% | 1370 |
|
|
2015
Q2 | $382K | Buy |
11,600
+700
| +6% | +$21.7K | ﹤0.01% | 1274 |
|
|
2015
Q1 | $313K | Buy |
10,900
+100
| +0.9% | +$2.87K | ﹤0.01% | 1360 |
|
|
2014
Q4 | $294K | Buy |
10,800
+200
| +2% | +$4.77K | ﹤0.01% | 1386 |
|
|
2014
Q3 | $226K | Sell |
10,600
-200
| -2% | -$4.58K | ﹤0.01% | 1526 |
|
|
2014
Q2 | $243K | Buy |
10,800
+250
| +2% | +$5.82K | ﹤0.01% | 1513 |
|
|
2014
Q1 | $267K | Buy |
10,550
+50
| +0.5% | +$1.26K | ﹤0.01% | 1311 |
|
|
2013
Q4 | $241K | Buy |
10,500
+200
| +2% | +$4.17K | ﹤0.01% | 1387 |
|
|
2013
Q3 | $196K | Buy |
+10,300
| New | +$184K | ﹤0.01% | 1442 |
|
Other funds holding EBS
